Semigran Marc - Aug 12, 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Development Officer
Signature
/s/ John R. Moore, Attorney-in-Fact for Semigran Marc
Stock symbol
EWTX
Transactions as of
Aug 12, 2024
Transactions value $
$0
Form type
4
Date filed
8/14/2024, 04:15 PM
Previous filing
Aug 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +139K $0.00 139K Aug 12, 2024 Common Stock 139K $17.05 Direct F1
transaction EWTX Restricted Stock Units Award $0 +23.1K $0.00 23.1K Aug 12, 2024 Common Stock 23.1K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest each month beginning on August 12, 2024, subject to the Reporting Person continuing as a service provider through each vest date.
F2 Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2024.